Krystal Bottom MD

Pediatric Hematology & Oncology•Asheville, NC

Pediatric Hem/Onc attending at Mission Hospital

Join to View Full Profile

11 Vanderbilt Park DrAsheville, NC 28803
Phone+1 828-213-1740
Fax+1 828-213-1742

Education & Training

Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1996
University of South Florida MorsaniResidency, Pediatrics, 1989 - 1992
University of Florida College of MedicineClass of 1989

Certifications & Licensure

NC State Medical License 1996 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
ACTIVE_NOT_RECRUITING
PHASE3
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
ACTIVE_NOT_RECRUITING
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
Recruiting
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
ACTIVE_NOT_RECRUITING
PHASE3
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
ACTIVE_NOT_RECRUITING
PHASE3
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment Start of enrollment: 2014 Mar 05
Recruiting
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
COMPLETED
Join now to see all

Publications & Presentations

PubMed

56 citations
Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
Christopher D. Turner, Sridharan Gururangan, James D. Eastwood, Krystal S. Bottom, Melody A. Watral
Neuro-Oncology. 2002-04-01
6 citations
Evaluation of Pre-radiotherapy Cyclophosphamide in Patients with Newly Diagnosed Glioblastoma Multiforme
Krystal S. Bottom, David M. Ashley, Henry S. Friedman, Darryl C. Longee
Journal of Neuro-Oncology. 2000-01-01
23 citations
Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis.
Thomas J. Cummings, Christine M. Hulette, Darryl C. Longee, Krystal S. Bottom, Roger E. McLendon
Clinical Neuropathology. 1999-07-01

Press Mentions

North Carolina Boy Holds onto Hope While Battling Rare Brain TumorJuly 7th, 2017

Krystal Bottom MD

Dr. Bottom is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.